Physician profile
Jeffrey A Frey
NPI 1013180744
$508.85
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $91.87 · 2021: $73.97.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $125.00 | 2019 | |
| Lundbeck LLC | $54.01 | 2019-2020 | |
| Neos Therapeutics, LP | $47.60 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $38.42 | 2019-2020 | |
| Abbvie INC. | $32.45 | 2021 | |
| Neuronetics, INC. | $24.74 | 2019 | |
| Neurocrine Biosciences, INC. | $24.40 | 2019 | |
| Livanova USA, INC. | $21.51 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.22 | 2020 | |
| Harmony Biosciences LLC | $20.01 | 2021 | |
| Allergan, INC. | $18.92 | 2020 | |
| Alkermes, INC. | $16.96 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.34 | 2019 | |
| Shire North American Group INC | $13.37 | 2019 | |
| Indivior INC. | $12.50 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $11.31 | 2019 | |
| Ironshore Pharmaceuticals INC. | $11.09 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.